🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Honoured to host HRH Duchess of Gloucester at our official opening of the Cambridge Heart and Lung Research Institute yesterday. Now the real work begins to undertake high impact translational science to benefit patients with cardiopulmonary conditions! @BHF Royal Papworth Hospital NHS FT 💙

Our TBX4 paper has just been accepted for publication in ATS Blue Journal !! Happy of having shared this scientific journey with so many giants in the field! Official twit when we have it online 🥳🥳🥳🥳

The peppered moth - never actually seen one in real life before (although this one sadly dead). One of the first evolutionary stories we heard at school featured this beautiful creature.

Today is a historic day for British Heart Foundation, as we announce #CureHeart as the winner of our £30m #BigBeatChallenge 🔬 I'm unbelievably proud that this incredible research, funded by our amazing supporters, could lead to the first cures for people with inherited muscle heart diseases

LockBody is hiring! Looking for talented, passionate scientists who want to change the future of cancer therapy: centessa.com/career-details/

Thrilled to announce that US Orphan Drug designation was granted to SerpinPC, our novel inhibitor of activated protein C, being investigated as a treatment of #hemophiliaB. We look forward to initiating registrational studies for SerpinPC later this year. bit.ly/3eDNx50

Today we announced a poster presentation of data from our oral small-molecule orexin receptor 2 (OX2R) agonist discovery pipeline at #SleepEurope 2022. The poster will be presented in Athens on Thurs., Sept. 29 at 12:15pm EEST. Read our press release: investors.centessa.com/news-releases/…

Fantastic to see RxCelerate Founder and CEO, Jill Reckless, featured in Sunday Times! bit.ly/3UQ4utV Jill has been an inspiration to just about everyone she has ever worked with

Great job of the International Consortium for Genetic Studies in PAH. Proud to be part of this dynamic team. @Pulmotension @Respifil InsermU999 Genetic counselling and testing in pulmonary arterial hypertension - A consensus statement erj.ersjournals.com/content/early/…

It's #PulmonaryHypertension Awareness Month. Centessa's advancing MGX292 as part of our mission to develop transformational medicines for patients with #PulmonaryArterialHypertension. Visit The Pulmonary Hypertension Association to learn more about PH Awareness month: bit.ly/3De9YGN

Today we announced that new data from an additional 18-months of continued treatment with SerpinPC from the OLE of our Phase 2a Study of SerpinPC in hemophilia was accepted for oral presentation at the 64th ASH Annual Meeting on Sat., Dec. 10 at 2:15pm CT. investors.centessa.com/news-releases/…

Amazing Accomplishment: our first joint paper is published in Blue Journal ATS Blue Journal !! Huge Thanks to all contributors and especially to Justyna Karolak for the leadership! Big research value, but also huge increase of credibility for TBX4Life! #tbx4 atsjournals.org/doi/abs/10.116…

Proud moment! My First, First Author paper is finally published! Happy Monday News! 🥳 An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis ➡️nature.com/articles/s4200… Communications Biology #PAH #PhD #PhDChat Here's the Tweetorial👇

Centessa hosted The Pulmonary Hypertension Association & individuals living with PH for an event to raise awareness of this complex disease. Learn how you can help spread awareness #PulmonaryArterialHypertension.

A lifetime pleasure to give a plenary talk at my home conference #winterBTS2022

investors.centessa.com/news-releases/…

Join Centessa and the Rare Disease community to help raise awareness of #RareDisease. Show your stripes in honor of #RareDiseaseDay and visit @RareDisease's website to get involved: bit.ly/3ZRqSFx

We are delighted to announce that today we have become the Victor Phillip Dahdaleh Heart & Lung Research Institute to honour a very generous philanthropic donation from Victor Dahdaleh Cambridge University Royal Papworth Hospital NHS FT 💙 CUHP

We have had lots of fun this morning celebrating the announcement of a £16 million gift to HLRI and are thrilled to change our name in honour of our generous benefactor. We are grateful to Victor & our other wonderful partners incl British Heart Foundation Royal Papworth Hospital Charity Cystic Fibrosis Trust Wolfson Foundation

ATP13A3 variants promote pulmonary arterial hypertension by disrupting polyamine transport academic.oup.com/cardiovascres/… Great to see this out. Wonderful collaboration with Peter Vangheluwe and team!